Business description: Bayer AG

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:

- agrochemicals (47.8%): herbicides, fungicides, insecticides, etc.;

- pharmaceutical products (38.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;

- OTC products and nutritional supplements (12.6%);

- other (0.7%).

Net sales are distributed geographically as follows: Germany (5.2%), Switzerland (1.2%), Europe/Middle East/Africa (23.6%), the United States (31.7%), North America (3.6%), China (7.7%), Asia/Pacific (9.6%), Brazil (9.3%) and Latin America (8.1%).

Number of employees: 88,502

Sales by Activity: Bayer AG

Fiscal Period: December20202021202220232024

Crop Science

18.85B 20.22B 25.18B 23.29B 22.31B

Pharmaceuticals

17.29B 18.37B 19.26B 18.11B 18.17B

Consumer Health

5.05B 5.29B 6.08B 6.03B 5.88B

All Other

372M 203M 219M 239M 328M

Enabling Functions and Consolidation

-163M -5M -1M -36M -72M
See all business segments

Geographical breakdown of sales: Bayer AG

Fiscal Period: December20202021202220232024

United States

12.88B 13.4B 15.68B 14.59B 14.8B

Europe / Middle East / Africa (Excl. Germany & Switzerland)

10.02B 10.56B 11.35B 11.07B 11B

Asia / Pacific (Excl.China)

4.78B 4.99B 5.19B 4.74B 4.47B

Brazil

2.99B 3.48B 5.32B 4.97B 4.32B

Latin America (Excl. Brazil)

2.91B 3.16B 3.97B 3.96B 3.76B

China

3.48B 3.86B 4.26B 3.62B 3.6B

Germany

2.36B 2.54B 2.48B 2.45B 2.41B

North America (Excl.United States)

1.47B 1.56B 1.89B 1.67B 1.68B

Switzerland

496M 542M 600M 567M 575M
See all geographic segments

Executive Committee: Bayer AG

Manager TitleAgeSince
Chief Executive Officer 59 31/05/2023
Director of Finance/CFO 56 31/05/2018
Chief Tech/Sci/R&D Officer 58 31/01/2021
Chief Tech/Sci/R&D Officer 56 31/05/2020
Investor Relations Contact - 31/10/2021
See BAYER AG governance

Composition of the Board of Directors: Bayer AG

Director TitleAgeSince
Director/Board Member 69 31/03/2002
Director/Board Member 55 31/03/2012
Director/Board Member 66 31/03/2022
Director/Board Member 64 31/10/2015
Director/Board Member 70 31/03/2017
Director/Board Member 60 31/03/2017
Chairman 68 27/04/2020
Director/Board Member 67 30/09/2019
Director/Board Member 68 27/04/2020
Director/Board Member 69 31/03/2021
Composition of the Board of Directors

Shareholders: Bayer AG

NameEquities%Valuation
Silchester International Investors LLP
2.994 %
29,409,766 2.994 % 1 040 M €
Harris Associates LP
2.981 %
29,285,913 2.981 % 1 036 M €
Amundi Asset Management SASU (Investment Management)
2.971 %
29,188,372 2.971 % 1 033 M €
Dodge & Cox
2.874 %
28,233,293 2.874 % 999 M €
Cobas Asset Management SGIIC SA
0.2368 %
2,326,082 0.2368 % 82 M €
NameEquities%Valuation
Kahn Brothers Group, Inc.
0.1727 %
6,787,253 0.1727 % 60 M €
Dodge & Cox
0.0398 %
1,562,425 0.0398 % 14 M €
Goldman Sachs Asset Management International
0.007721 %
303,393 0.007721 % 3 M €
Great Lakes Advisors LLC
0.003615 %
142,040 0.003615 % 1 M €
RhumbLine Advisers LP
0.001775 %
69,761 0.001775 % 617 036 €
List of BAYER AG shareholders

Holdings: Bayer AG

NameEquities%Valuation
32,102,999 71.43% 1,667,626,238 $
5,285,489 7.69% 62,567,557 $
2,742,338 4.4% 14,232,734 $
4,050,997 10.79% 7,089,245 $
3,162,157 12.03% 7,051,610 $
12,675,838 14.52% 6,908,332 $
1,615,201 7.22% 1,889,785 $
7,256 0.07% 2,736 $

Company details: Bayer AG

Bayer AG

Kaiser-Wilhelm-Allee 1

51368, Leverkusen

+49 214 30 1

http://www.bayer.com
address Bayer AG(BAYN)

Group companies: Bayer AG

NameCategory and Sector
Movies/Entertainment
Movies/Entertainment
See all subsidiaries

Other Pharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
+0.89%+7.21%+81.02%-30.56% 41.52B
+1.16%-3.86%+24.27%+175.25% 879B
+3.29%+0.59%+38.40%+17.53% 482B
+0.98%-2.20%+28.18%+38.10% 394B
+2.12%+2.61%+26.87%+5.71% 335B
-0.57%-1.31%+28.56%+19.02% 281B
-1.31%-1.84%+18.77%+23.33% 254B
+0.75%-4.55%-3.35%-10.26% 240B
+3.31%+1.74%-60.50%-32.93% 207B
+0.49%-8.70%+14.37%+13.18% 169B
Average +0.93%-1.45%+19.66%+21.84% 328.31B
Weighted average by Cap. +1.06%-2.07%+19.86%+55.57%
See all sector performances
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
36.62EUR
Average target price
33.42EUR
Spread / Average Target
-8.74%
Consensus

Quarterly revenue - Rate of surprise